• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Spectrophotometric determination of certain benzimidazole proton pump inhibitors.某些苯并咪唑质子泵抑制剂的分光光度法测定
Indian J Pharm Sci. 2008 Jul-Aug;70(4):507-10. doi: 10.4103/0250-474X.44605.
2
Comparison of inhibitory effects of the proton pump-inhibiting drugs omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole on human cytochrome P450 activities.质子泵抑制药物奥美拉唑、埃索美拉唑、兰索拉唑、泮托拉唑和雷贝拉唑对人细胞色素P450活性的抑制作用比较。
Drug Metab Dispos. 2004 Aug;32(8):821-7. doi: 10.1124/dmd.32.8.821.
3
Comparison of Antioxidant Effects of the Proton Pump-Inhibiting Drugs Omeprazole, Esomeprazole, Lansoprazole, Pantoprazole, and Rabeprazole.质子泵抑制剂药物奥美拉唑、埃索美拉唑、兰索拉唑、泮托拉唑和雷贝拉唑的抗氧化作用比较。
Pharmacology. 2020;105(11-12):645-651. doi: 10.1159/000506232. Epub 2020 Apr 14.
4
Stereoselective disposition of proton pump inhibitors.质子泵抑制剂的立体选择性分布
Clin Drug Investig. 2008;28(5):263-79. doi: 10.2165/00044011-200828050-00001.
5
Chiral separation in the class of proton pump inhibitors by chromatographic and electromigration techniques: An overview.手性分离在质子泵抑制剂类中的色谱和电泳技术:概述。
Electrophoresis. 2021 Sep;42(17-18):1761-1789. doi: 10.1002/elps.202100032. Epub 2021 May 27.
6
Qualimetric analysis of proton pump inhibitors in Ukraine.乌克兰质子泵抑制剂的质量分析
Wiad Lek. 2019;72(9 cz 2):1769-1773.
7
Esomeprazole 40 mg provides more effective intragastric acid control than lansoprazole 30 mg, omeprazole 20 mg, pantoprazole 40 mg and rabeprazole 20 mg in patients with gastro-oesophageal reflux symptoms.在患有胃食管反流症状的患者中,40毫克埃索美拉唑比30毫克兰索拉唑、20毫克奥美拉唑、40毫克泮托拉唑和20毫克雷贝拉唑能更有效地控制胃内酸度。
Eur J Clin Pharmacol. 2004 Oct;60(8):531-9. doi: 10.1007/s00228-004-0804-6. Epub 2004 Sep 2.
8
Determination of Proton Pump Inhibitors by Spectrophotometric, Chromatographic and by Hyphenated Techniques: A Review.分光光度法、色谱法及联用技术测定质子泵抑制剂:综述
Crit Rev Anal Chem. 2021;51(6):527-548. doi: 10.1080/10408347.2020.1750339. Epub 2020 Apr 20.
9
Gastric acid control with esomeprazole, lansoprazole, omeprazole, pantoprazole, and rabeprazole: a five-way crossover study.埃索美拉唑、兰索拉唑、奥美拉唑、泮托拉唑和雷贝拉唑对胃酸的控制:一项五交叉研究。
Am J Gastroenterol. 2003 Dec;98(12):2616-20. doi: 10.1111/j.1572-0241.2003.08783.x.
10
Evaluation of six proton pump inhibitors as inhibitors of various human cytochromes P450: focus on cytochrome P450 2C19.评价六种质子泵抑制剂对各种人细胞色素 P450 的抑制作用:重点关注细胞色素 P450 2C19。
Drug Metab Dispos. 2012 Sep;40(9):1698-711. doi: 10.1124/dmd.112.045575. Epub 2012 May 30.

引用本文的文献

1
Design, synthesis of benzimidazole tethered 3,4-dihydro-2H-benzo[e] [1, 3] oxazines as anticancer agents.苯并咪唑键联 3,4-二氢-2H-苯并[e][1,3]恶嗪类衍生物的设计与合成及其抗癌活性研究。
Mol Divers. 2024 Jun;28(3):1347-1361. doi: 10.1007/s11030-023-10661-3. Epub 2023 May 26.
2
Development and validation of dissolution testings in acidic media for rabeprazole sodium delayed-release capsules.雷贝拉唑钠缓释胶囊在酸性介质中溶出度测试的开发与验证
Drug Dev Ind Pharm. 2016 Oct;42(10):1669-77. doi: 10.3109/03639045.2016.1161644. Epub 2016 Apr 11.

本文引用的文献

1
Spectrophotometric methods for the determination of omeprazole in bulk form and pharmaceutical formulations.用于测定原料药和药物制剂中奥美拉唑的分光光度法。
Talanta. 1997 Jul;44(7):1211-7. doi: 10.1016/s0039-9140(97)83117-7.
2
Determination of lansoprazole in pharmaceutical capsules by flow injection analysis using UV-detection.采用紫外检测流动注射分析法测定药用胶囊中的兰索拉唑。
J Pharm Biomed Anal. 2004 Sep 21;36(1):145-8. doi: 10.1016/j.jpba.2004.04.015.
3
Voltammetric behaviour of rabeprazole at a glassy carbon electrode and its determination in tablet dosage form.雷贝拉唑在玻碳电极上的伏安行为及其在片剂剂型中的测定。
Farmaco. 2004 Jul;59(7):515-8. doi: 10.1016/j.farmac.2004.03.009.
4
Validation of the spectrophotometric determination of omeprazole and pantoprazole sodium via their metal chelates.通过金属螯合物分光光度法测定奥美拉唑和泮托拉唑钠的方法验证
J Pharm Biomed Anal. 2003 Oct 15;33(3):411-21. doi: 10.1016/s0731-7085(03)00233-4.
5
Spectrophotometric and chromatographic determination of rabeprazole in presence of its degradation products.
J Pharm Biomed Anal. 2003 Feb 26;31(2):229-42. doi: 10.1016/s0731-7085(02)00445-4.
6
Enantiomeric determination of pantoprazole in human plasma by multidimensional high-performance liquid chromatography.采用多维高效液相色谱法测定人血浆中泮托拉唑的对映体。
J Chromatogr B Analyt Technol Biomed Life Sci. 2002 Jan 5;766(1):153-60. doi: 10.1016/s0378-4347(01)00472-8.
7
High-performance liquid chromatographic assay for the simultaneous determination of lansoprazole enantiomers and metabolites in human liver microsomes.高效液相色谱法同时测定人肝微粒体中兰索拉唑对映体及其代谢产物
J Chromatogr B Biomed Sci Appl. 2001 Jun 5;757(1):127-33. doi: 10.1016/s0378-4347(01)00135-9.
8
Rabeprazole for the prevention of pathologic and symptomatic relapse of erosive or ulcerative gastroesophageal reflux disease. Rebeprazole Study Group.雷贝拉唑预防糜烂性或溃疡性胃食管反流病的病理及症状复发。雷贝拉唑研究组
Am J Gastroenterol. 2000 Nov;95(11):3081-8. doi: 10.1111/j.1572-0241.2000.03179.x.
9
Spectrophotometric methods for the determination of lansoprazole and pantoprazole sodium sesquihydrate.
J Pharm Biomed Anal. 2000 Feb;22(1):45-58. doi: 10.1016/s0731-7085(99)00275-7.
10
Determination of omeprazole in human plasma by high-performance liquid chromatography.
J Chromatogr B Biomed Sci Appl. 1997 Feb 7;689(1):239-43. doi: 10.1016/s0378-4347(96)00283-6.

某些苯并咪唑质子泵抑制剂的分光光度法测定

Spectrophotometric determination of certain benzimidazole proton pump inhibitors.

作者信息

Syed A A, Syeda Ayesha

机构信息

Department of Studies in Chemistry, University of Mysore, Mysore-570 006, India.

出版信息

Indian J Pharm Sci. 2008 Jul-Aug;70(4):507-10. doi: 10.4103/0250-474X.44605.

DOI:10.4103/0250-474X.44605
PMID:20046782
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2792556/
Abstract

Spectrophotometric method for the determination of certain proton pump inhibitors belonging to the benzimidazole class of compounds has been developed. The method is based on the reaction of omeprazole, lansoprazole, pantoprazole, rabeprazole and esomeprazole with iron (III) and subsequent reaction with ferricyanide under neutral condition which yields Prussian blue product with maximum absorption at 720-730 nm. The commonly encountered excipients and additives that often accompany pharmaceutical preparations did not interfere with the determination. The method was applied for the determination of omeprazole, lansoprazole, pantoprazole, rabeprazole and esomeprazole in pharmaceutical preparations and no difference was found statistically. Thus, the spectrophotometric method can be applied as inexpensive, rapid, easy, accurate and precise method for the routine analysis of the five proton pump inhibitors in pharmaceutical preparations.

摘要

已开发出用于测定某些属于苯并咪唑类化合物的质子泵抑制剂的分光光度法。该方法基于奥美拉唑、兰索拉唑、泮托拉唑、雷贝拉唑和埃索美拉唑与铁(III)的反应,随后在中性条件下与铁氰化物反应,生成在720 - 730 nm处有最大吸收的普鲁士蓝产物。药物制剂中常见的辅料和添加剂不干扰测定。该方法用于测定药物制剂中的奥美拉唑、兰索拉唑、泮托拉唑、雷贝拉唑和埃索美拉唑,统计学上未发现差异。因此,分光光度法可作为一种廉价、快速、简便、准确且精密的方法,用于药物制剂中五种质子泵抑制剂的常规分析。